Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma
Article in Cancer and Metastasis Reviews (February 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Cancer and Metastasis Reviews (February 2024)
Article in Medicine (June 2023)
Article in Journal of Translational Medicine (March 2023)